Company intelligence / Profile preview
StrongHolt Therapeutics
Gainesville, Florida, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
StrongHolt Therapeutics is an early-stage biotechnology company focused on the development of novel therapeutic agents for the treatment of cancer. The company leverages its expertise in medicinal chemistry and oncology biology to identify and optimize small molecule candidates targeting critical pathways in tumor progression. Currently operating in the pre-clinical phase, StrongHolt aims to advance its lead programs toward IND-enabling studies. The company is part of the emerging biotech ecosystem in the Southeastern United States, often associated with regional innovation hubs.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on StrongHolt Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StrongHolt Therapeutics.